A detailed history of Colonial Trust CO / Sc transactions in Novartis Ag stock. As of the latest transaction made, Colonial Trust CO / Sc holds 3,147 shares of NVS stock, worth $347,177. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,147
Previous 3,127 0.64%
Holding current value
$347,177
Previous $315,000 3.49%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $1,905 - $2,169
20 Added 0.64%
3,147 $304,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $5,683 - $6,307
-60 Reduced 1.88%
3,127 $318,000
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $1,850 - $2,098
-20 Reduced 0.62%
3,187 $321,000
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $20,487 - $23,759
-256 Reduced 7.39%
3,207 $295,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $258,374 - $302,181
3,463 New
3,463 $263,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $237B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.